Shawn Cross Insider Profile
4 Followers
Shawn Cross, CFO at Pacira Pharmaceuticals, holds 105.34K shares in Pacira Pharmaceuticals (Ticker: PCRX), holds 136.35K shares in Cyclo Therapeutics (Ticker: CYTH), holds 545.50K shares in Applied Molecular Transport (Ticker: AMTI).
Profitable Transactions
3 out of 3 Profitable Transactions
Average Return
+85.80%
Average return per transaction
Time Frame
Compare to
Insider Roles
CFO
Roles that Shawn Cross holds in companies
Most Profitable Insider Trade
Stock:
Applied Molecular Transport
(AMTI)
(AMTI)
Rating:Informative Sell
Date:Jun 03, 2022 - Jun 03, 2023
Return:+92.30%
The most profitable trade made by Shawn Cross
Shawn Cross's Trading History
Pacira Pharmaceuticals
Apr 24, 2026
CFO
Uninformative Buy
212.88K
$2.54M
Applied Molecular Transport
Nov 24, 2023
―
Informative Sell
17.73K
$143.47K
Cyclo Therapeutics
Mar 03, 2025
―
Uninformative Buy
―
$98.17K
List of latest transactions for each holding click on a transaction to see Shawn Cross's performance on stock
You May Also Like
Shawn Cross insider profile FAQ
What is the percentage of profitable transactions made by Shawn Cross?
The percentage of profitable transactions made by Shawn Cross is 100%.
What is the average return per transaction made by Shawn Cross?
The average return per transaction made by Shawn Cross is 85.80%.
What stocks does Shawn Cross hold?
Shawn Cross holds: PCRX, AMTI, CYTH stocks.
What was Shawn Cross’s latest transaction?
Shawn Cross latest transaction was an Uninformative Buy of $212.88K.
What was Shawn Cross's most profitable transaction?
Shawn Cross’s most profitable transaction was an Informative Sell of AMTI stock on June 3, 2022. The return on the trade was 92.30%.
What is Shawn Cross's role in Pacira Pharmaceuticals?
Shawn Cross's role in Pacira Pharmaceuticals is CFO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.